Prevention of irinotecan plus5-fluorouracil/leucovorin-induced diarrhoea by oral administration of neomycin plus bacitracin in first-line treatment of advanced colorectal cancer

Line Treatment ◽

First Line ◽

Faculty Opinions recommendation of Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958548.793464802 ◽

2012 ◽

Author(s):

Yiqian Nancy You ◽

Brian Keith Bednarski

Keyword(s):

Colorectal Cancer ◽

Phase Iii ◽

Line Treatment ◽

First Line ◽

Double Blind ◽

Phase Iii Study ◽

Treatment breaks in first line treatment of advanced colorectal cancer: an individual patient data meta-analysis

Cancer Treatment Reviews ◽

10.1016/j.ctrv.2021.102226 ◽

2021 ◽

pp. 102226

Author(s):

Richard Adams ◽

Kaitlyn Goey ◽

Benoist Chibaudel ◽

Miriam Koopman ◽

Cornelis Punt ◽

...

Keyword(s):

Colorectal Cancer ◽

Individual Patient Data ◽

Meta Analysis ◽

Patient Data ◽

Line Treatment ◽

First Line ◽

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

The Lancet Oncology ◽

10.1016/s1470-2045(11)70102-4 ◽

2011 ◽

Vol 12 (7) ◽

pp. 642-653 ◽

Cited By ~ 169

Author(s):

Richard A Adams ◽

Angela M Meade ◽

Matthew T Seymour ◽

Richard H Wilson ◽

Ayman Madi ◽

...

Keyword(s):

Colorectal Cancer ◽

Combination Chemotherapy ◽

Line Treatment ◽

First Line ◽

Phase 3 ◽

Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study

European Journal of Cancer ◽

10.1016/j.ejca.2014.12.020 ◽

2015 ◽

Vol 51 (4) ◽

pp. 473-481 ◽

Cited By ~ 10

Author(s):

Maria Di Bartolomeo ◽

Andrea Ciarlo ◽

Alessandro Bertolini ◽

Sandro Barni ◽

Claudio Verusio ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Medical Oncology ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

First-line treatment with modified FOLFOXIRI plus bevacizumab in patients with locally advanced colorectal cancer

Annals of Cancer Research and Therapy ◽

10.4993/acrt.28.44 ◽

2020 ◽

Vol 28 (1) ◽

pp. 44-48 ◽

Cited By ~ 1

Author(s):

Yasufumi Yamada ◽

Kazuhiko Yoshimatsu ◽

Hajime Yokomizo ◽

Sachiyo Okayama ◽

Hiroyuki Maeda ◽

...

Keyword(s):

Colorectal Cancer ◽

Locally Advanced ◽

Line Treatment ◽

First Line ◽

Locally Advanced Colorectal Cancer ◽

Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?

Annals of Oncology ◽

10.1093/annonc/mdi196 ◽

2005 ◽

Vol 16 (6) ◽

pp. 845-846 ◽

Cited By ~ 15

Author(s):

C.J.A. Punt

Keyword(s):

Colorectal Cancer ◽

Line Treatment ◽

First Line ◽

A genotype-directed phase I–IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer

British Journal of Cancer ◽

10.1038/bjc.2011.206 ◽

2011 ◽

Vol 105 (1) ◽

pp. 53-57 ◽

Cited By ~ 70

Author(s):

E Marcuello ◽

D Páez ◽

L Paré ◽

J Salazar ◽

A Sebio ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Dose Finding ◽

Line Treatment ◽

First Line ◽

Finding Study ◽

Dose Finding Study ◽

Irinotecan plus raltitrexed may be effective as a first-line treatment for advanced colorectal cancer,

Inpharma Weekly ◽

10.2165/00128413-200414430-00033 ◽

2004 ◽

Vol &NA; (1443) ◽

pp. 14

Author(s):

&NA;

Keyword(s):

Colorectal Cancer ◽

Line Treatment ◽

First Line ◽

TOMOX compared to FOLFOX4 as first-line treatment in patients (pts) with advanced colorectal cancer (ACRC): Preliminary results of a multicenter randomized phase II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3599 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3599-3599

Author(s):

C. Grávalos ◽

C. García-Girón ◽

A. I. León ◽

A. Salud ◽

B. Esteban ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Preliminary Results ◽

Randomized Phase Ii ◽

Phase II randomized trial on protracted 5-fluorouracil infusion plus oxaliplatin (FOX) versus capecitabine plus oxaliplatin (XELOX) as first-line treatment in advanced colorectal cancer (ACRC): Preliminary results of the Italian FOCA Study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3617 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3617-3617 ◽

Cited By ~ 1

Author(s):

A. Martoni ◽

C. Pinto ◽

F. Di Fabio ◽

G. Lelli ◽

A. L. Gentile ◽

...

Keyword(s):

Colorectal Cancer ◽

Randomized Trial ◽

Phase Ii ◽

Line Treatment ◽

First Line ◽

Preliminary Results ◽